Clinical Trial Update: A Trial of Atorvastatin as an Anti-Inflammatory Agent in Non-Cystic Fibrosis Bronchiectasis [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating atorvastatin as an anti-inflammatory therapy for bronchiectasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiectasis

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: University of Edinburgh | Conditions: Bronchiectasis | Phase 4 | Status: COMPLETED